Design Therapeutics DSGN
NASDAQ DSGN
$10.65 -0.15 (-1.39%)
At close: Nov 10, 2026 · 4:00 PM EST

Design Therapeutics (DSGN) Return on Equity [ROE] (2021 - 2026)

Updated

Design Therapeutics (DSGN) posted Return on Equity [ROE] of -33.72% for Q2 2026, down 4.92 percentage points from -28.80% a year earlier and down 1.34 percentage points from the prior quarter.

Analysis

Design Therapeutics (DSGN) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For FY2025, Design Therapeutics' Return on Equity [ROE] came in at -30.70%, down 11.62 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a four-year change of -11.38 percentage points (FY2021 to FY2025).
  • In prior years, Design Therapeutics' Return on Equity [ROE] was -19.08% in FY2024 (+3.02 pp), -22.10% in FY2023 (-3.05 pp), -19.06% in FY2022 (+0.27 pp) and -19.33% in FY2021.
  • Quarterly Return on Equity [ROE] has run from a low of -33.86% in Q4 2025 to a high of -7.20% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last five quarters, with an average year-over-year change of -3.80 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2024, with a gain of 8.47 percentage points; the weakest was Q4 2025, with a drop of 13.81 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -32.38% (Q1 2026), -33.86% (Q4 2025) and -32.68% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Design Therapeutics 679.31 Mn -179.36 Mn - -36.67%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -36.67%
Jun 30, 2026 -33.72%
Mar 31, 2026 -32.38%
Dec 31, 2025 -33.86%
Sep 30, 2025 -32.68%
Jun 30, 2025 -28.80%
Mar 31, 2025 -23.91%
Dec 31, 2024 -20.05%
Sep 30, 2024 -19.88%
Jun 30, 2024 -21.42%
Mar 31, 2024 -24.72%
Dec 31, 2023 -27.79%
Sep 30, 2023 -28.35%
Jun 30, 2023 -27.17%
Mar 31, 2023 -23.71%
Dec 31, 2022 -20.23%
Sep 30, 2022 -17.00%
Jun 30, 2022 -14.15%
Mar 31, 2022 -11.57%
Dec 31, 2021 -9.26%
API Access

Design Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DSGN&period=max&api_key=YOUR_API_KEY